Log in

Relevant bibliographies by topics / Anisamida / Journal articles

To see the other types of publications on this topic, follow the link: Anisamida.

Journal articles on the topic 'Anisamida'

Author: Grafiati

Published: 11 September 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 33 journal articles for your research on the topic 'Anisamida.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Katsuura, K., and V. Snieckus. "Directed ortho metalation reactions. Convergent synthesis of "angular" anthracyclinones ochromycinone and X-14881 C." Canadian Journal of Chemistry 65, no. 1 (January 1, 1987): 124–30. http://dx.doi.org/10.1139/v87-020.

Full text

Abstract:

Convergent syntheses of the benz[a]anthraquinone natural products X-14881 C (2c) and ochromycinone (2d) have been achieved using aromatic directed metalation strategies. Key steps involve (a) the condensations of dilithiated cis-tetralol (13a) with the aldehydo o-anisamide 14 and of methoxymethyl protected aldehyde 17b with lithiated o-anisamide (18) to give, after acid-catalyzed cyclization, the phthalide 16, and (b) the regiospeciflc hydroxyselenylation of anthraquinone 22 to provide the hydroxyselenide 23.

APA, Harvard, Vancouver, ISO, and other styles

2

Li, Shao-Lu, Yaoyi Wang, Jingfang Zhang, Wei Wei, and Hua Lu. "Targeted delivery of a guanidine-pendant Pt(iv)-backboned poly-prodrug by an anisamide-functionalized polypeptide." Journal of Materials Chemistry B 5, no. 48 (2017): 9546–57. http://dx.doi.org/10.1039/c7tb02513k.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Fitzgerald, Kathleen A., Kamil Rahme, Jianfeng Guo, Justin D. Holmes, and Caitriona M. O'Driscoll. "Anisamide-targeted gold nanoparticles for siRNA delivery in prostate cancer – synthesis, physicochemical characterisation and in vitro evaluation." Journal of Materials Chemistry B 4, no. 13 (2016): 2242–52. http://dx.doi.org/10.1039/c6tb00082g.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Dasargyri, Athanasia, Carole D. Kümin, and Jean-Christophe Leroux. "Targeting Nanocarriers with Anisamide: Fact or Artifact?" Advanced Materials 29, no. 7 (November 25, 2016): 1603451. http://dx.doi.org/10.1002/adma.201603451.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Yang, Weijing, Yan Zou, Fenghua Meng, Jian Zhang, and Zhiyuan Zhong. "Anisamide-functionalized polymersomes targeted deliver granzyme B to lung xenografts." Journal of Controlled Release 259 (August 2017): e139. http://dx.doi.org/10.1016/j.jconrel.2017.03.282.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Guo, Jianfeng, Julien R. Ogier, Stephane Desgranges, Raphael Darcy, and Caitriona O′Driscoll. "Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice." Biomaterials 33, no. 31 (November 2012): 7775–84. http://dx.doi.org/10.1016/j.biomaterials.2012.07.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Atala, Anthony. "Re: Anisamide-Targeted Cyclodextrin Nanoparticles for siRNA Delivery to Prostate Tumours in Mice." Journal of Urology 190, no. 1 (July 2013): 357. http://dx.doi.org/10.1016/j.juro.2013.03.098.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Yang, Weijing, Fenghua Meng, and Zhiyuan Zhong. "Anisamide-functionalized intelligent polymersomes mediate targeted delivery of methotrexate into lung cancer cells." Journal of Controlled Release 213 (September 2015): e114. http://dx.doi.org/10.1016/j.jconrel.2015.05.191.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Clayden, Jonathan, and Kirill Tchabanenko. "Synthesis of (±)-kainic acid by dearomatising cyclisation of a lithiated N-benzyl p-anisamide." Chemical Communications, no. 4 (2000): 317–18. http://dx.doi.org/10.1039/a909325g.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Banerjee, Rajkumar, Pradeep Tyagi, Song Li, and Leaf Huang. "Anisamide-targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells." International Journal of Cancer 112, no. 4 (September 15, 2004): 693–700. http://dx.doi.org/10.1002/ijc.20452.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Dasargyri, Athanasia, Pablo Hervella, Ailsa Christiansen, Steven T. Proulx, Michael Detmar, and Jean-Christophe Leroux. "Findings questioning the involvement of Sigma-1 receptor in the uptake of anisamide-decorated particles." Journal of Controlled Release 224 (February 2016): 229–38. http://dx.doi.org/10.1016/j.jconrel.2016.01.021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Clayden, Jonathan, and Kirill Tchabanenko. "ChemInform Abstract: Synthesis of (.+-.)-Kainic Acid by Dearomatizing Cyclization of a Lithiated N-Benzyl p-Anisamide." ChemInform 31, no. 22 (June 8, 2010): no. http://dx.doi.org/10.1002/chin.200022165.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Jaccard, Guy, Pierre-Alain Carrupt, and Jürgen Lauterwein. "Study of intramolecular hydrogen bonding ino-anisic acid ando-anisamide by17O NMR andAb initio MO calculations." Magnetic Resonance in Chemistry 26, no. 3 (March 1988): 239–44. http://dx.doi.org/10.1002/mrc.1260260312.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Thombare, R. D., and D. T. Tayade. "Synthesis of 4-Amino-5-Substitutedthiocarbamido-N-[2-(Diethylamino)Ethyl]-O-Anisamides." Asian Journal of Research in Chemistry 10, no. 2 (2017): 221. http://dx.doi.org/10.5958/0974-4150.2017.00037.2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Lu, Ling, Yan Zou, Weijing Yang, Fenghua Meng, Chao Deng, Ru Cheng, and Zhiyuan Zhong. "Anisamide-Decorated pH-Sensitive Degradable Chimaeric Polymersomes Mediate Potent and Targeted Protein Delivery to Lung Cancer Cells." Biomacromolecules 16, no. 6 (May 12, 2015): 1726–35. http://dx.doi.org/10.1021/acs.biomac.5b00193.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Qu, Ding, Mengying Jiao, Haijiao Lin, Chunli Tian, Guowei Qu, Jingwei Xue, Lingjing Xue, Caoyun Ju, and Can Zhang. "Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment." Carbohydrate Polymers 229 (February 2020): 115498. http://dx.doi.org/10.1016/j.carbpol.2019.115498.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Wang, Limei, Jin Pei, Zhongcheng Cong, Yifang Zou, Tianmeng Sun, Fionán Davitt, Adrià Garcia-Gil, et al. "Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice." International Journal of Nanomedicine Volume 14 (March 2019): 1817–33. http://dx.doi.org/10.2147/ijn.s192520.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Fitzgerald, Kathleen A., Meenakshi Malhotra, Matt Gooding, Florence Sallas, James C. Evans, Raphael Darcy, and Caitriona M. O’Driscoll. "A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor." International Journal of Pharmaceutics 499, no. 1-2 (February 2016): 131–45. http://dx.doi.org/10.1016/j.ijpharm.2015.12.055.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Misra, Santosh K., Parikshit Moitra, Paturu Kondaiah, and Santanu Bhattacharya. "Co-liposomes having anisamide tagged lipid and cholesteryl tryptophan trigger enhanced gene transfection in sigma receptor positive cells." Colloids and Surfaces B: Biointerfaces 142 (June 2016): 130–40. http://dx.doi.org/10.1016/j.colsurfb.2016.02.044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Sarkis, Monira, Esther Ghanem, and Kamil Rahme. "Jumping on the Bandwagon: A Review on the Versatile Applications of Gold Nanostructures in Prostate Cancer." International Journal of Molecular Sciences 20, no. 4 (February 23, 2019): 970. http://dx.doi.org/10.3390/ijms20040970.

Full text

Abstract:

Prostate cancer (PCa) has remarkably emerged as a prominent disease in the face of the male population. Conventional treatments like prostatectomy or radiation can be curative only if PCa is diagnosed at an early stage. In the field of targeted therapy, a bevy of novel therapeutic approaches have left a landmark in PCa treatment and have proven to extend survival via distinct modes of actions. Nanotherapy has started to take root and has become the hype of the century by virtue of its abundant advantages. Scientists have invested a great deal of interest in the development of nanostructures such as gold nanoparticles (AuNPs), which hold particularly great hope for PCa theranostics. In this article, we present an overview of the studies published after 1998 that involve the use of different functionalized AuNPs to treat and diagnose PCa. Special reference is given to various in vitro and in vivo methods employed to shuttle AuNPs to PCa cells. Major studies show an enhancement of either detection or treatment of PCa when compared to their non-targeted counterparts, especially when AuNPs are tagged with specific ligands, such as antibodies, tea natural extracts, folate, anisamide, receptor inhibitors, and chitosan. Future approaches of treatment are dependent on those worthy multifunctional molecules, and are dictated by their ability to achieve a more versatile cancer therapeutic approach.

APA, Harvard, Vancouver, ISO, and other styles

21

Garg, Charu, Ashwani Kumar Sharma, Alka Gupta, and Pradeep Kumar. "Anisamido-Polyethylenimines as Efficient Nonviral Vectors for the Transport of Plasmid DNA to Sigma Receptor–Bearing Cells In Vitro." Journal of Pharmaceutical Sciences 108, no. 4 (April 2019): 1552–58. http://dx.doi.org/10.1016/j.xphs.2018.11.037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Urandur, Sandeep, Venkatesh Teja Banala, Ravi Prakash Shukla, Naresh Mittapelly, Gitu Pandey, Navodayam Kalleti, Kalyan Mitra, et al. "Anisamide-Anchored Lyotropic Nano-Liquid Crystalline Particles with AIE Effect: A Smart Optical Beacon for Tumor Imaging and Therapy." ACS Applied Materials & Interfaces 10, no. 15 (March 26, 2018): 12960–74. http://dx.doi.org/10.1021/acsami.7b19109.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

S. Hifnawy, Mohamed, Hossam M. Hassan, Rabab Mohammed, Mohamed M. Fouda, Ahmed M. Sayed, Ahmed A. Hamed, Sameh F. AbouZid, Mostafa E. Rateb, Hani A. Alhadrami, and Usama Ramadan Abdelmohsen. "Induction of Antibacterial Metabolites by Co-Cultivation of Two Red-Sea-Sponge-Associated Actinomycetes Micromonospora sp. UR56 and Actinokinespora sp. EG49." Marine Drugs 18, no. 5 (May 5, 2020): 243. http://dx.doi.org/10.3390/md18050243.

Full text

Abstract:

Liquid chromatography coupled with high resolution mass spectrometry (LC-HRESMS)-assisted metabolomic profiling of two sponge-associated actinomycetes, Micromonospora sp. UR56 and Actinokineospora sp. EG49, revealed that the co-culture of these two actinomycetes induced the accumulation of metabolites that were not traced in their axenic cultures. Dereplication suggested that phenazine-derived compounds were the main induced metabolites. Hence, following large-scale co-fermentation, the major induced metabolites were isolated and structurally characterized as the already known dimethyl phenazine-1,6-dicarboxylate (1), phenazine-1,6-dicarboxylic acid mono methyl ester (phencomycin; 2), phenazine-1-carboxylic acid (tubermycin; 3), N-(2-hydroxyphenyl)-acetamide (9), and p-anisamide (10). Subsequently, the antibacterial, antibiofilm, and cytotoxic properties of these metabolites (1–3, 9, and 10) were determined in vitro. All the tested compounds except 9 showed high to moderate antibacterial and antibiofilm activities, whereas their cytotoxic effects were modest. Testing against Staphylococcus DNA gyrase-B and pyruvate kinase as possible molecular targets together with binding mode studies showed that compounds 1–3 could exert their bacterial inhibitory activities through the inhibition of both enzymes. Moreover, their structural differences, particularly the substitution at C-1 and C-6, played a crucial role in the determination of their inhibitory spectra and potency. In conclusion, the present study highlighted that microbial co-cultivation is an efficient tool for the discovery of new antimicrobial candidates and indicated phenazines as potential lead compounds for further development as antibiotic scaffold.

APA, Harvard, Vancouver, ISO, and other styles

24

Galal, Alaaeldin M. F., Walid Fayad, Walaa S. A. Mettwally, Sanaa K. Gomaa, Esam R. Ahmed, Heba A. El-Refai, and Atef G. Hanna. "Cytotoxicity of multicellular cancer spheroids, antibacterial, and antifungal of selected sulfonamide derivatives coupled with a salicylamide and/or anisamide scaffold." Medicinal Chemistry Research 28, no. 9 (June 14, 2019): 1425–40. http://dx.doi.org/10.1007/s00044-019-02382-w.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Evans, James C., Meenakshi Malhotra, Kathleen A. Fitzgerald, Jianfeng Guo, Michael F. Cronin, Caroline M. Curtin, Fergal J. O’Brien, Raphael Darcy, and Caitriona M. O’Driscoll. "Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model." Molecular Pharmaceutics 14, no. 1 (November 23, 2016): 42–52. http://dx.doi.org/10.1021/acs.molpharmaceut.6b00646.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Garg, Neeraj K., Priya Dwivedi, Christopher Campbell, and Rajeev K. Tyagi. "Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: An improved understanding of lung cancer therapeutic intervention." European Journal of Pharmaceutical Sciences 47, no. 5 (December 2012): 1006–14. http://dx.doi.org/10.1016/j.ejps.2012.09.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Goodwin, Tyler J., and Leaf Huang. "On the article “Findings questioning the involvement of Sigma-1 receptor in the uptake of anisamide-decorated particles” [J. Control. Release 224 (2016) 229–238]." Journal of Controlled Release 243 (December 2016): 382–85. http://dx.doi.org/10.1016/j.jconrel.2016.11.022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Luan, Xue, Kamil Rahme, Zhongcheng Cong, Limei Wang, Yifang Zou, Yan He, Hao Yang, Justin D. Holmes, Caitriona M. O'Driscoll, and Jianfeng Guo. "Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice." European Journal of Pharmaceutics and Biopharmaceutics 137 (April 2019): 56–67. http://dx.doi.org/10.1016/j.ejpb.2019.02.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Billman, George E., Melanie S. Houle, Heinrich C. Englert, and Heinz Gögelein. "Effects of a Novel Cardioselective ATP-Sensitive Potassium Channel Antagonist, 1-[[5-[2-(5-Chloro-o-anisamido)ethyl]-β-methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, Sodium Salt (HMR 1402), on Susceptibility to Ventricular Fibrillation Induced by Myocardial Ischemia: In Vitro and in Vivo Studies." Journal of Pharmacology and Experimental Therapeutics 309, no. 1 (January 13, 2004): 182–92. http://dx.doi.org/10.1124/jpet.103.061416.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Yao, Weihe, Chenyu Liu, Ning Wang, Hengjun Zhou, Hailiang Chen, and Weihong Qiao. "Anisamide-modified dual-responsive drug delivery system with MRI capacity for cancer targeting therapy." Journal of Molecular Liquids, July 2021, 116889. http://dx.doi.org/10.1016/j.molliq.2021.116889.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Ramzy, Lydia, Abdelkader A. Metwally, Maha Nasr, and Gehanne A. S. Awad. "Novel thymoquinone lipidic core nanocapsules with anisamide-polymethacrylate shell for colon cancer cells overexpressing sigma receptors." Scientific Reports 10, no. 1 (July 3, 2020). http://dx.doi.org/10.1038/s41598-020-67748-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

"SYNTHESIS OF 6-{4-AMINO-N-[2-(DIETHYLAMINO)ETHYL]-O-ANISAMIDO-5- YL}-AMINO-2-THIO-3-SUBSTITUTEDAMINO,4-SUBSTITUTEDIMINO-1,3,5- THIADIZINES." International Journal Of Medical Science And Clinical Invention 4, no. 12 (December 9, 2017). http://dx.doi.org/10.18535/ijmsci/v4i12.05.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Galal, Alaaeldin, and khaled mahmoud. "Antiproliferative Evaluation and Molecular Docking studies of some Sulfonyl-α-L-amino acid Derivatives coupled with Anisamide Scaffold." Egyptian Journal of Chemistry, March 7, 2021, 0. http://dx.doi.org/10.21608/ejchem.2021.64272.3381.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!